Pediatric Price Transparency: Still Opaque With Opportunities for Improvement

Laura J Faherty1,2, Charlene A Wong3,4, Jordyn Feingold5

  • 1Robert Wood Johnson Foundation Clinical Scholars Program.

Hospital Pediatrics
|September 7, 2017
PubMed

Insights

Online pediatric price transparency is limited, but phone or online estimate tools can help families understand out-of-pocket costs. Improving access to healthcare pricing information is crucial for informed decision-making.

Area of Science:

  • Health Services Research
  • Health Economics
  • Consumer Health Informatics

Background:

  • Rising healthcare costs place a greater financial burden on families.
  • Price transparency in healthcare is increasingly important for consumers.
  • Pediatric care pricing information is often difficult for families to access.

Purpose of the Study:

  • To assess the availability of online price transparency data for pediatric care.
  • To evaluate the consumer experience of obtaining out-of-pocket cost estimates from children's hospitals.
  • To identify effective strategies for providing pediatric healthcare price information.

Main Methods:

  • Audit of 45 children's hospital websites and 38 state-based price transparency websites (2015-2016).
  • Analysis of price availability and characteristics of cost estimate tools.
  • Secret shopper methodology to request out-of-pocket estimates for tonsillectomy-adenoidectomy.

Main Results:

  • Only 18% of children's hospital websites listed prices; 27% offered estimate tools (phone or online).
  • Hospitals with phone estimate lines provided liability information (mean $6008).
  • 39% of state websites distinguished pediatric from adult care prices; only one had an estimate tool.

Conclusions:

  • Meaningful online price transparency for pediatric care is not widely available.
  • Phone lines and online forms are effective for providing out-of-pocket price information.
  • Significant opportunities exist to enhance pediatric price transparency.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
373
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.5K